[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370464-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-370464-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","machine-learning-prediction-of-her2-low-expression-in-breast-cancers-based-on-hematoxylineosin-stained-slides","Machine learning prediction of HER2-low expression in breast cancers based on hematoxylin–eosin-stained slides","","Treatment with HER2-targeted therapies is recommended for HER2-positive breast cancer defined by gene amplification or protein overexpression, while new HER2-targeted agents show benefit in HER2-low disease. Accurate detection of HER2 expression therefore becomes essential. Traditional assessment relies on time-consuming, technically challenging HER2 immunohistochemistry (IHC). This work develops an AI classification model using whole-slide H&E images to predict HER2 status and support economical, interpretable evaluation.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/machine-learning-prediction-of-her2-low-expression-in-breast-cancers-based-on-hematoxylineosin-stained-slides/370464/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/machine-learning-prediction-of-her2-low-expression-in-breast-cancers-based-on-hematoxylineosin-stained-slides/370464.png","ImageObject",300,407,{"name":42,"@type":43},"Rhys","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-22","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"Why is predicting HER2 expression from H&E slides clinically valuable?","Question",{"text":62,"@type":63},"HER2 IHC assessment is time-consuming, costly, and technically difficult for many basic hospitals. Predicting HER2 directly from hematoxylin–eosin stained slides can enable faster and more economical evaluation.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"How does the proposed AI method assess HER2 status?",{"text":67,"@type":63},"The study builds an AI classification model that uses whole-slide images of H&E-stained slides to automatically assess HER2 status.",{"name":69,"@type":60,"acceptedAnswer":70},"What performance and interpretability did the model achieve?",{"text":71,"@type":63},"The model performed strongly on both TCGA-BRCA and an in-house USTC-BC dataset, with reported AUC values of 0.795 ± 0.028 and 0.688 ± 0.008. Attention heatmaps were used to visualize results and demonstrate interpretability.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},370464,1790188676,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":79,"read_time":143,"preview_page_count":33,"preview_urls":144},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Du et al. Breast Cancer Research (2025) 27:57 [https://doi.org/10.1186/s13058-025-01998-8](https://doi.org/10.1186/s13058-025-01998-8)  \nBreast Cancer Research  \n RESEARCH Open Access  \nMachine learning prediction of HER2-low expression in breast cancers based on hematoxylin–eosin-stained slides  \nJun Du1,2†, Jun Shi3†, Dongdong Sun4†, Yifei Wang4, Guanfeng Liu5, Jingru Chen5, Wei Wang1,2, Wenchao Zhou2,7*, Yushan Zheng6* and Haibo Wu1,2,7*  \nAbstract  \nBackground Treatment with HER2-targeted therapies is recommended for HER2-positive breast cancer patients with HER2 gene amplification or protein overexpression. Interestingly, recent clinical trials of novel HER2-targeted therapies demonstrated promising efficacy in HER2-low breast cancers, raising the prospect of including a HER2-low category (immunohistochemistry, IHC) score of 1 + or 2 + with non-amplified in-situ hybridization for HER2-targeted treatments, which necessitated the accurate detection and evaluation of HER2 expression in tumors. Traditionally, HER2 protein levels are routinely assessed by IHC in clinical practice, which not only requires significant time consumption and financial investment but is also technically challenging for many basic hospitals in developing countries. Therefore, directly predicting HER2 expression by hematoxylin-eosin (HE) staining should be of significant clinical values, and machine learning may be a potent technology to achieve this goal.  \nMethods In this study, we developed an artificial intelligence (AI) classification model using whole slide image of HEstained slides to automatically assess HER2 status.  \nResults A publicly available TCGA-BRCA dataset and an in-house USTC-BC dataset were applied to evaluate our AI model and the state-of-the-art method SlideGraph + in terms of accuracy (ACC), the area under the receiver operating characteristic curve (AUC), and F1 score. Overall, our AI model achieved the superior performance in HER2 scoring in both datasets with AUC of 0.795 ± 0.028 and 0.688 ± 0.008 on the USCT-BC and TCGA-BRCA datasets, respectively. In addition, we visualized the results generated from our AI model by attention heatmaps, which proved that our AI model had strong interpretability.  \nConclusion Our AI model is able to directly predict HER2 expression through HE images with strong interpretability, and has a better ACC particularly in HER2-low breast cancers, which provides a method for AI evaluation of HER2 status and helps to perform HER2 evaluation economically and efficiently. It has the potential to assist pathologists to improve diagnosis and assess biomarkers for companion diagnostics.  \nKeywords Breast cancer, Machine learning, Prediction, Hematoxylin–eosin, HER2  \n†Jun Du, Jun Shi and Dongdong Sun contributed equally to this work.  \n*Correspondence: Wenchao Zhou [WZAZ@ustc.edu.cn](WZAZ@ustc.edu.cn)[ ](WZAZ@ustc.edu.cn)Yushan Zheng  \n[yszheng@buaa.edu.cn](yszheng@buaa.edu.cn)[ ](yszheng@buaa.edu.cn)HaiboWu [wuhaibo@ustc.edu.cn](wuhaibo@ustc.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need t","cbCailjpBICgq5Bg","https://ap.wps.com/l/cbCailjpBICgq5Bg","pdf",2924442,"English","# Abstract\n# Introduction\n## HER2-targeted therapy and HER2 status categories\n## HER2 IHC scoring standards and challenges\n# Methods\n# Results\n# Conclusion","[{\"question\":\"Why is predicting HER2 expression from H\\u0026E slides clinically valuable?\",\"answer\":\"HER2 IHC assessment is time-consuming, costly, and technically difficult for many basic hospitals. Predicting HER2 directly from hematoxylin–eosin stained slides can enable faster and more economical evaluation.\"},{\"question\":\"How does the proposed AI method assess HER2 status?\",\"answer\":\"The study builds an AI classification model that uses whole-slide images of H\\u0026E-stained slides to automatically assess HER2 status.\"},{\"question\":\"What performance and interpretability did the model achieve?\",\"answer\":\"The model performed strongly on both TCGA-BRCA and an in-house USTC-BC dataset, with reported AUC values of 0.795 ± 0.028 and 0.688 ± 0.008. Attention heatmaps were used to visualize results and demonstrate interpretability.\"}]","Machine learning prediction of HER2-low expression in breast cancers based on hematoxylin–eosin-stained slides | PDF",25,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6902522dcf236587bf64b060c30ca852.webp",983,1305,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5585f3673abb0c322c99ba898f78599.webp",982,1304,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e849c62091d9cdce3b2139c2ace780fd.webp",981,1303,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34686b9818df61f75228a7e9a34f7214.webp",980,1301]